The UvA-LINKER will give you a range of other options to find the full text of a publication (including a direct link to the full-text if it is located on another database on the internet).
De UvA-LINKER biedt mogelijkheden om een publicatie elders te vinden (inclusief een directe link naar de publicatie online als deze beschikbaar is in een database op het internet).

Search results

Record: oai:ARNO:395626

AuthorsA. Mocroft, O. Kirk, P. Reiss, S. de Wit, D. Sedlacek, M. Beniowski, J. Gatell, A.N. Phillips, B. Ledergerber, J.D. Lundgren
TitleEstimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
JournalAIDS
Volume24
Year2010
Issue11
Pages1667-1678
ISSN02699370
FacultyAMC-UvA
AbstractObjectives: Chronic kidney disease (CKD) in HIV-positive persons might be caused by both HIV and traditional or non-HIV-related factors. Our objective was to investigate long-term exposure to specific antiretroviral drugs and CKD. Design: A cohort study including 6843 HIV-positive persons with at least three serum creatinine measurements and corresponding body weight measurements from 2004 onwards. Methods: CKD was defined as either confirmed (two measurements >= 3 months apart) estimated glomerular filtration rate (eGFR) of 60 ml/min per 1.73 m(2) or below for persons with baseline eGFR of above 60 ml/min per 1.73 m(2) or confirmed 25% decline in eGFR for persons with baseline eGFR of 60 ml/min per 1.73 m(2) or less, using the Cockcroft-Gault formula. Poisson regression was used to determine factors associated with CKD. Results: Two hundred and twenty-five (3.3%) persons progressed to CKD during 21 482 person-years follow-up, an incidence of 1.05 per 100 person-years follow-up [95% confidence interval (CI) 0.91-1.18]; median follow-up was 3.7 years (interquartile range 2.8-5.7). After adjustment for traditional factors associated with CKD and other confounding variables, increasing cumulative exposure to tenofovir [incidence rate ratio (IRR) per year 1.16, 95% CI 1.06-1.25, P<0.0001), indinavir (IRR 1.12, 95% CI 1.06-1.18, P<0.0001), atazanavir (IRR 1.21, 95% CI 1.09-1.34, P=0.0003) and lopinavir/r (IRR 1.08, 95% CI 1.01-1.16, P=0.030) were associated with a significantly increased rate of CKD. Consistent results were observed in wide-ranging sensitivity analyses, although of marginal statistical significance for lopinavir/r. No other antiretroviral dugs were associated with increased incidence of CKD. Conclusion: In this nonrandomized large cohort, increasing exposure to tenofovir was associated with a higher incidence of CKD, as was true for indinavir and atazanavir, whereas the results for lopinavir/r were less clear. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
Document typeArticle
Document finderUvA-Linker